New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
15:37 EDTGILD, DATA, JKHY, ULTI, HAIN, ATO, BWLD, DV, HI, XOOM, AXS, CVD, AFL, AMP, EQR, CERN, CHRW, UNM, MAC, EW, GNW, GIMONotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Gilead Sciences (GILD), consensus 50c; AFLAC (AFL), consensus $1.39; Ameriprise Financial (AMP), consensus $1.81; Equity Residential (EQR), consensus 69c; Cerner (CERN), consensus 39c; CH Robinson Worldwide (CHRW), consensus 68c; Unum Group (UNM), consensus 84c; Macerich (MAC), consensus 92c; Edwards Lifesciences (EW), consensus 71c; Genworth Financial (GNW), consensus 30c; Covance (CVD), consensus 84c; AXIS Capital (AXS), consensus $1.47; Tableau Software (DATA), consensus 0c; Jack Henry & Associates (JKHY), consensus 60c; Ultimate Software (ULTI), consensus 41c; Hain Celestial (HAIN), consensus 87c; Atmos Energy (ATO), consensus 86c; Buffalo Wild Wings (BWLD), consensus $1.07; DeVry (DV), consensus 73c; Hillenbrand (HI), consensus 52c; Xoom (XOOM), consensus (1c); Gigamon (GIMO), consensus 12c.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 23, 2014
11:38 EDTBWLDBrinker retreats after analyst downgrades on industry concerns
Subscribe for More Information
10:02 EDTEQROn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:48 EDTEQREquity Residential initiated with a Neutral at Mizuho
Subscribe for More Information
July 22, 2014
16:17 EDTXOOMXoom sees FY14 EPS 16c-24c, consensus 22c
Subscribe for More Information
16:16 EDTXOOMXoom sees Q3 EPS (1c)-2c, consensus 4c
Subscribe for More Information
16:14 EDTXOOMXoom reports Q2 EPS 9c, consensus 5c
Subscribe for More Information
16:12 EDTGIMOGigamon appoints Mike Burns as CFO
Subscribe for More Information
07:57 EDTEWHouse Energy & Commerce Committee to hold a hearing
The Subcommittee on Health holds a hearing entitled, "21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication" with CEO Mussallem at Edwards Lifesciences on July 22 at 3 pm. Webcast Link
06:14 EDTGILDGilead July weekly volatility elevated into Q2
Subscribe for More Information
July 21, 2014
16:00 EDTGILDOptions Update; July 21, 2014
iPath S&P 500 VIX Short-Term Futures up 65c to 28.53. Option volume leaders: AAPL FB NFLX DG CMCSA GILD PBR TWTR TSLA according to Track Data.
15:28 EDTCERNCerner August volatility increase into Q2
Cerner August call implied volatility is at 36, September is at 31, December is at 24; compared to its 26-week average of 28 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 22.
09:38 EDTGILDActive equity options trading on open
Subscribe for More Information
08:11 EDTDATATableau risk/reward favorable, says Morgan Stanley
Subscribe for More Information
07:21 EDTGILDGilead could be hurt by new HCV drugs, says Wells Fargo
Noting that data on a new Merck (MRK) HCV treatment is expected in November, Wells Fargo thinks Merck's HCV drug could be combined with Gilead's (GILD) Sovaldi to shorten the duration of treatment to four weeks. Other companies could take similar actions, and Gilead's per patient revenues would be significantly reduced if this occurs, the firm warned. However, it continues to have an upbeat outlook on Gilead heading into what it sees as a strong quarter and is still upbeat on the company's long-term HCV opportunity. It keeps an Outperform rating on Gilead.
06:43 EDTGILDGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
July 20, 2014
12:46 EDTGILDGilead drug cocktail helps treat HIV/HCV-coinfected patients, JAMA says
Subscribe for More Information
July 18, 2014
10:03 EDTDATAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:03 EDTEQROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:33 EDTDVDeVry discloses receipt of letter from NY AG regarding ads, marketing
DeVry disclosed in a regulatory filing that on July 15 DeVry Group received a letter from the Office of the Attorney General of the State of New York requesting cooperation with the NYOAG’s inquiry into whether recent television advertisements and website marketing regarding DeVry University may have violated federal and state laws prohibiting false advertising and deceptive practices. The letter requests relevant information from January 1, 2011, to the present to enable NYOAG to make a determination of what action, if any, is warranted. "DeVry Group intends to provide the Office of the Attorney General with its full cooperation with a view toward demonstrating the compliant nature of its practices. The timing or outcome of this matter, or its possible impact on DeVry Group’s business, financial condition or results of operations, cannot be predicted at this time," the company stated.
06:11 EDTEQREquity Residential downgraded to Market Perform at Raymond James
Raymond James downgraded Equity Residential to Market Perform from Outperform.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use